Key points from article :
Desperate patients are ready to do everything to access to new treatments.
Easily misled by headlines reporting early stage successes.
Quantitative and qualitative inconstancy in products availability worldwide.
European Committee for Advanced Therapy (CAT) has raised concern about absence of rigorous scientific and ethical requirements.
variability even within Europe where many products only authorized in individual nations.
Deaths and serious complications have occured in Germany and Italy.
